Skip to main content
Erschienen in: Medical Oncology 2/2012

01.06.2012 | Original Paper

Telomere shortening occurs early during gastrocarcinogenesis

verfasst von: Yunchuan Mu, Qing Zhang, Linhang Mei, Xiaosun Liu, Weili Yang, Jiren Yu

Erschienen in: Medical Oncology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

When telomeres are shortened to a critical length, they will initiate chromosomal instability (CIN) and may finally cause tumorigenesis. The purpose of the present study was to evaluate the shortened telomere as a potential biomarker for tumorigenesis in gastric carcinoma. The telomeres in matched cancer and adjacent noncancer mucosa samples from 86 gastric carcinoma patients were measured by real-time polymerase chain reaction (PCR). According to the International Union Against Cancer (UICC), tumor stages were classified into four groups: stage I (n = 23), stage II (n = 20), stage III (n = 23), and stage IV (n = 20). Telomere length decreased with aging in both adjacent noncancer mucosa and cancer tissue (r = −0.261 (P = 0.008) and r = −0.27 (P = 0.012), respectively). The telomere length of UICC stage I tumors was significantly shorter than the average telomere length in adjacent noncancer mucosa (P = 0.023). Telomere length increased gradually with increasing UICC stage (P = 0.032). The telomere length of UICC stage IV tumors was significantly longer, when compared to that in noncancer mucosa (P = 0.019) and stage I tumors (P = 0.002). In summary, telomere length undergoes shortening in early stage gastric carcinoma and lengthening in advanced gastric carcinoma. Additionally, telomere shortening may initiate the tumorigenesis of gastric carcinoma.
Literatur
1.
Zurück zum Zitat Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477–90.PubMedCrossRef Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477–90.PubMedCrossRef
3.
Zurück zum Zitat Milne AN, Carneiro F, O’Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126(5):615–28.PubMedCrossRef Milne AN, Carneiro F, O’Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126(5):615–28.PubMedCrossRef
4.
Zurück zum Zitat Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119(5):265–72.PubMedCrossRef Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119(5):265–72.PubMedCrossRef
5.
Zurück zum Zitat Bornschein J, Kandulski A, Selgrad M, Malfertheiner P. From gastric inflammation to gastric cancer. Dig Dis. 2010;28(4–5):609–14.PubMedCrossRef Bornschein J, Kandulski A, Selgrad M, Malfertheiner P. From gastric inflammation to gastric cancer. Dig Dis. 2010;28(4–5):609–14.PubMedCrossRef
6.
Zurück zum Zitat Chin L, et al. p53 deficiency rescues the advance effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999;97(4):527–38.PubMedCrossRef Chin L, et al. p53 deficiency rescues the advance effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999;97(4):527–38.PubMedCrossRef
7.
Zurück zum Zitat Aida J, et al. Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method. Hum Pathol. 2007;38(8):1192–200.PubMedCrossRef Aida J, et al. Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method. Hum Pathol. 2007;38(8):1192–200.PubMedCrossRef
8.
Zurück zum Zitat Sobin LH, Wittekind CH. TNM classification of malignant tumors. 6th ed. New York, NY, USA: Wiley; 2002. Sobin LH, Wittekind CH. TNM classification of malignant tumors. 6th ed. New York, NY, USA: Wiley; 2002.
9.
10.
11.
Zurück zum Zitat Blackbum EH. Structure and function of telomeres. Nature. 1991;350:569–73.CrossRef Blackbum EH. Structure and function of telomeres. Nature. 1991;350:569–73.CrossRef
12.
Zurück zum Zitat Djojosubroto MW, Choi YS, Lee HW, Rudolph KL. Telomeres and telomerase in aging, regeneration, and cancer. Mol Cells. 2003;15(2):164–75.PubMed Djojosubroto MW, Choi YS, Lee HW, Rudolph KL. Telomeres and telomerase in aging, regeneration, and cancer. Mol Cells. 2003;15(2):164–75.PubMed
13.
Zurück zum Zitat Furugori E, et al. Telomere shortening in gastric carcinoma with aging despite telomerase activation. J Cancer Res Clin Oncol. 2000;126(8):481–5.PubMedCrossRef Furugori E, et al. Telomere shortening in gastric carcinoma with aging despite telomerase activation. J Cancer Res Clin Oncol. 2000;126(8):481–5.PubMedCrossRef
14.
Zurück zum Zitat Nakamura K, et al. Correlation of telomere lengths in normal and cancers tissue in the large bowel. Cancer Lett. 2000;158:179–84.PubMedCrossRef Nakamura K, et al. Correlation of telomere lengths in normal and cancers tissue in the large bowel. Cancer Lett. 2000;158:179–84.PubMedCrossRef
15.
Zurück zum Zitat Gumus-Akay G, et al. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognosyic significance. Genet Mol Res. 2007;6(1):41–9.PubMed Gumus-Akay G, et al. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognosyic significance. Genet Mol Res. 2007;6(1):41–9.PubMed
16.
Zurück zum Zitat Nakamura Y, Tahara E, Tahara H, Yasui W, Ide T. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol Carcinog. 1999;16(4):312–20.CrossRef Nakamura Y, Tahara E, Tahara H, Yasui W, Ide T. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol Carcinog. 1999;16(4):312–20.CrossRef
17.
Zurück zum Zitat Liu XN, et al. Constitutive telomere length and gastric cancer risk: case–control analysis in Chinese Han population. Cancer Sci. 2009;100(7):1300–5.PubMedCrossRef Liu XN, et al. Constitutive telomere length and gastric cancer risk: case–control analysis in Chinese Han population. Cancer Sci. 2009;100(7):1300–5.PubMedCrossRef
18.
Zurück zum Zitat Blackburn EH. Telomeres and telomerase: their mechanism of action and the effects of action and the effects of altering their functions. FEBS Lett. 2005;579:859–62.PubMedCrossRef Blackburn EH. Telomeres and telomerase: their mechanism of action and the effects of action and the effects of altering their functions. FEBS Lett. 2005;579:859–62.PubMedCrossRef
19.
Zurück zum Zitat Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol. 1992;225(4):951–60.PubMedCrossRef Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol. 1992;225(4):951–60.PubMedCrossRef
20.
Zurück zum Zitat Artandi SE, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–5.PubMedCrossRef Artandi SE, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–5.PubMedCrossRef
21.
Zurück zum Zitat Cosme-Blanco W, Chang S. Dual roles of telomere dysfunction in initiation and suppression of tumorigenesis. Exp Cell Res. 2008;314:1973–9.PubMedCrossRef Cosme-Blanco W, Chang S. Dual roles of telomere dysfunction in initiation and suppression of tumorigenesis. Exp Cell Res. 2008;314:1973–9.PubMedCrossRef
22.
Zurück zum Zitat Gertler R, et al. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol. 2004;22:1807–14.PubMedCrossRef Gertler R, et al. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol. 2004;22:1807–14.PubMedCrossRef
23.
Zurück zum Zitat Kim NW, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011.PubMedCrossRef Kim NW, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011.PubMedCrossRef
Metadaten
Titel
Telomere shortening occurs early during gastrocarcinogenesis
verfasst von
Yunchuan Mu
Qing Zhang
Linhang Mei
Xiaosun Liu
Weili Yang
Jiren Yu
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 2/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9866-3

Weitere Artikel der Ausgabe 2/2012

Medical Oncology 2/2012 Zur Ausgabe

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.